Newsfeeds - Spark Newswire

2 minute read

Selecta Biosciences Announces Strategic Licensing Agreement With Takeda To Develop Next-Generation Gene Therapies For Patients With Lysosomal Storage Disorders

Today, 9:42 PM

Selecta Biosciences, Inc. (NASDAQ:SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today

SELB

4 minute read

The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More

By Shanthi Rexaline

Today, 9:42 PM

Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks.

ADVM

7 minute read

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates

By Shanthi Rexaline

Today, 9:42 PM

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned.

ANIP

1 minute read

Takeda Says ‘Human Error’ Reason Behind Contaminated Moderna COVID-19 Vaccines

By Vandana Singh

Today, 9:42 PM

Takeda Pharmaceutical Co Ltd (NYSE: TAK) blamed "human error" as the cause of metal contaminants found in some batches of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine.

MRNA

1 minute read

Takeda In-Licenses Hunter Syndrome Candidate

By Vandana Singh

Today, 9:42 PM

Takeda Pharmaceutical Company Limited (NYSE:TAK) and JCR Pharmaceuticals Co Ltd have announced an exclusive collaboration and license agreement to commercialize JR-141 (pabinafusp alfa)…

TAK

1 minute read

Takeda Guilty Of Supply Contract Breach With AbbVie For Prostate Cancer Drug

By Vandana Singh

Today, 9:42 PM

In a spat between Takeda Pharmaceutical Co Ltd (NYSE:TAK) and AbbVie Inc (NYSE:ABBV) for Lupron (leuprorelin), a Delaware judge has issued a ruling…

ABBV

4 minute read

Options

9 Health Care Stocks Showing Unusual Options Activity In Today’s Session

By Benzinga Insights

Today, 9:42 PM

This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.

CRVS

4 minute read

The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight

By Shanthi Rexaline

Today, 9:42 PM

Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical readouts and IPOs were among the catalysts for the week.

AGTC

5 minute read

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study

By Shanthi Rexaline

Today, 9:42 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)

ACHL

1 minute read

Takeda’s Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion

By Vandana Singh

Today, 9:42 PM

The FDA has approved Takeda Pharmaceutical Co Ltd’s (NYSE:TAK) Exkivity (mobocertinib) for non-small cell lung cancer (NSCLC) settings. The approval comes…

TAK